Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Share News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Cellular Goods shareholder Story disposes of 3% interest

Mon, 02nd Aug 2021 19:18

Cellular Goods PLC - UK-based provider of premium consumer products based on lab-made cannabinoids - John Story sells entire holding of 15.0 million shares, or 3% interest in company, at an undisclosed sum.

At the current closing price of 7.08p, the sale's estimated value would be around GBP1.1 million.

Current stock price: 7.08 pence

Year-to-date change: down 63% since end of February

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
22 Dec 2010 10:08

Small caps round-up: Eckoh, Manroy, Ortac...

Speech recognition specialist Eckoh has secured a three-year contract with hotel and restaurant giant Whitbread, making it one of the group's largest clients to date.   Eckoh will provide its payment card industry data security standard service to Whitbread's hotel brand Premier Inn, which is due to

Read more
14 Jul 2010 07:35

Cubus Lux Raises GBP325,000 Via Placing At 14P >CBX.LN

LONDON (Dow Jones)--Cubus Lux PLC (CBX.LN), a leisure and tourism company in Croatia, said Wednesday it has raised GBP325,000 through the issue of 2.32 million new ordinary shares at 14 pence per share which will be used to finance certain project costs and short term working capital commitments.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.